Back to SNDX

Palo Alto Investors LP → SNDX

Palo Alto Investors LP SNDX Position History

Syndax Pharmaceuticals, Inc. • Healthcare

Quarters held
6
Latest value
$11.2M
Q3 2026
Peak value
$20.2M
First seen
Q4 2025

Dollar value over time

Show data table
PeriodPosition value
Q4 2025$16.7M
Q1 2026$20.2M
Q2 2026$18.9M
Q2 2026$18.9M
Q2 2026$18.9M
Q3 2026$11.2M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$11.2M596.4K——
Q2 2026$18.9M865.0K——
Q2 2026$18.9M865.0K——
Q2 2026$18.9M865.0K——
Q1 2026$20.2M865.0K——
Q4 2025$16.7M794.5K——

Other funds holding SNDX

Other Palo Alto Investors LP positions

INSM

INSMED INC

$85.2M
PTCT

PTC THERAPEUTICS INC

$75M
PTCT

PTC THERAPEUTICS INC

$75M
PTCT

PTC THERAPEUTICS INC

$75M
AMSF

AMICUS THERAPEUTICS INC

$74.1M
ACAD

ACADIA PHARMACEUTICALS INC

$72.5M
ACAD

ACADIA PHARMACEUTICALS INC

$72.5M
ACHC

ACADIA PHARMACEUTICALS INC

$72.5M